Pharmacology and Toxicology
-
Ribavirin shows antiviral activity against SARS-CoV-2 and downregulates the activity of TMPRSS2 and the expression of ACE2 In Vitro
This article has 21 authors:Reviewed by ScreenIT
-
Discovery of Clioquinol and Analogues as Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus 2 Infection, ACE2 and ACE2 - Spike Protein Interaction In Vitro
This article has 4 authors:Reviewed by ScreenIT
-
Small-Molecule In Vitro Inhibitors of the Coronavirus Spike – ACE2 Protein-Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2
This article has 4 authors:Reviewed by ScreenIT
-
In Vivo Pharmacokinetic Study of Remdesivir Dry Powder for Inhalation in Hamsters
This article has 8 authors:Reviewed by ScreenIT
-
Remdesivir Metabolite GS-441524 Effectively Inhibits SARS-CoV-2 Infection in Mice Models
This article has 16 authors:Reviewed by ScreenIT
-
A comparison of Remdesivir versus Au 22 Glutathione 18 in COVID-19 golden hamsters: a better therapeutic outcome of gold compound
This article has 22 authors:Reviewed by ScreenIT
-
Losartan promotes cell survival following SARS-CoV-2 infection in vitro
This article has 7 authors:Reviewed by ScreenIT
-
Combined in silico docking and in vitro antiviral testing for drug repurposing identified lurasidone and elbasvir as SARS-CoV-2 and HCoV-OC43 inhibitors
This article has 9 authors:Reviewed by ScreenIT
-
An expedited approach towards the rationale design of non-covalent SARS-CoV-2 main protease inhibitors with in vitro antiviral activity
This article has 15 authors:Reviewed by ScreenIT
-
Genetic determinants of COVID-19 drug efficacy revealed by genome-wide CRISPR screens
This article has 18 authors:Reviewed by ScreenIT